Market Cap (In USD)
8735.00
Revenue (In USD)
-
Net Income (In USD)
-
Avg. Volume
224.00
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 1.0E-4-0.30005
- PE
- -
- EPS
- -
- Beta Value
- -76.579
- ISIN
- US75988J1060
- CUSIP
- 75988J106
- CIK
- 1016708
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Harmel S. Rayat
- Employee Count
- -
- Website
- https://www.renovacareinc.com
- Ipo Date
- 1996-05-30
- Details
- RenovaCare, Inc., a development-stage biotech and medical device company, focuses on the research, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System, a treatment methodology for cell isolation for the regeneration of human skin cells; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. RenovaCare, Inc. has a strategic collaboration StemCell Systems GmbH for isolating and spraying self-donated stem cells to regenerate tissues and organs. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona.
More Stocks
-
3962Change Inc.
3962
-
DUKB
-
RVV
-
ASY
-
LAGNAMLagnam Spintex Limited
LAGNAM
-
2599
-
ALTBGThe Blockchain Group
ALTBG
-
EQTLEquital Ltd.
EQTL